Birt-Hogg-Dubé syndrome: Metalloproteinase activity and response to doxycycline

Clinics

Volumn 67, Issue 12, 2012, Pages 1501-1504

  Pimenta, Suzana Pinheiro ^a   Baldi, Bruno Guedes ^a   do Nascimento, Ellen Caroline Toledo ^a   Mauad, Thais ^a   Kairalla, Ronaldo Adib ^a   Carvalho, Carlos Roberto Ribeiro ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; GELATINASE B; MATRIX METALLOPROTEINASE INHIBITOR;

ADULT; ARTICLE; BIRT HOGG DUBE SYNDROME; CASE REPORT; ENZYMOLOGY; FEMALE; HUMAN; METABOLISM; PEDIGREE;

ADULT; BIRT-HOGG-DUBE SYNDROME; DOXYCYCLINE; FEMALE; HUMANS; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASE INHIBITORS; PEDIGREE;

EID: 84872278775     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.6061/clinics/2012(12)25     Document Type: Article

References (23)

1. Schmidt LS, Nickerson ML, Warren MB, Glenn GM, Toro JR, Merino MJ, et al. Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt-Hogg-Dube syndrome. Am J Hum Genet. 2005;76(6):1023-33, http://dx.doi.org/10.1086/430842.
2. Birt AR, Hogg GR, Dube WJ. Hereditary multiple fibrofolliculomas with trichodiscomas and acrochordons. Arch Dermatol. 1977;113(12):1674-7, http://dx.doi.org/10.1001/archderm.1977.01640120042005.
3. Toro JR, Glenn G, Duray P, Darling T, Weirich G, Zbar B, et al. Birt-Hogg-Dube syndrome: a novel marker of kidney neoplasia. Arch Dermatol. 1999;135(10):1195-202, http://dx.doi.org/10.1001/archderm. 135.10.1195.
4. Toro JR, Pautler SE, Stewart L, Glenn GM, Weinreich M, Toure O, et al. Lung cysts, spontaneous pneumothorax, and genetic associations in 89 families with Birt-Hogg-Dube syndrome. Am J Respir Crit Care Med. 2007;175(10):1044-53, http://dx.doi.org/10.1164/rccm.200610-1483OC.
5. Frohlich BA, Zeitz C, Matyas G, Alkadhi H, Tuor C, Berger W, et al. Novel mutations in the folliculin gene associated with spontaneous pneumothorax. Eur Respir J. 2008;32(5):1316-20, http://dx.doi.org/10. 1183/09031936.00132707.
6. Kalhan R, Yeldandi AV, Jain M. A 48-year-old woman with skin lesions, renal masses, and spontaneous pneumothorax. Chest. 2007;131(2):624-7, http://dx.doi.org/10.1378/chest.06-0559.
7. Elkington PT, Friedland JS. Matrix metalloproteinases in destructive pulmonary pathology. Thorax. 2006;61(3):259-66, http://dx.doi.org/10. 1136/thx.2005.051979.
8. Colombat M, Caudroy S, Lagonotte E, Mal H, Danel C, Stern M, et al. Pathomechanisms of cyst formation in pulmonary light chain deposition disease. Eur Respir J. 2008;32(5):1399-403, http://dx.doi.org/10.1183/09031936.00132007.
9. Chung AW, Yang HH, Radomski MW, van Breemen C. Long-term doxycycline is more effective than atenolol to prevent thoracic aortic aneurysm in marfan syndrome through the inhibition of matrix metalloproteinase-2 and-9. Circ Res. 2008;102(8):e73-85, http://dx.doi. org/10.1161/CIRCRESAHA.108.174367.
10. Moses MA, Harper J, Folkman J. Doxycycline treatment for lymphangioleiomyomatosis with urinary monitoring for MMPs. N Engl J Med. 2006;354(24):2621-2, http://dx.doi.org/10.1056/NEJMc053410.
11. Pimenta SP, Baldi BG, Acencio MM, Kairalla RA, Carvalho CR. Doxycycline use in patients with lymphangioleiomyomatosis: safety and efficacy in metalloproteinase blockade. J Bras Pneumol. 2011;37(4):424-30, http://dx.doi.org/10.1590/S1806-37132011000400003.
12. Hayashi T, Rush WL, Travis WD, Liotta LA, Stetler-Stevenson WG, Ferrans VJ. Immunohistochemical study of matrix metalloproteinases and their tissue inhibitors in pulmonary Langerhans' cell granulomatosis. Arch Pathol Lab Med. 1997;121(9):930-7.
13. Hayashi T, Fleming MV, Stetler-Stevenson WG, Liotta LA, Moss J, Ferrans VJ, et al. Immunohistochemical study of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in pulmonary lymphangioleiomyomatosis (LAM). Hum Pathol. 1997;28(9):1071-8, http://dx.doi. org/10.1016/S0046-8177(97)90061-7.
14. Matsui K, Takeda K, Yu ZX, Travis WD, Moss J, Ferrans VJ. Role for activation of matrix metalloproteinases in the pathogenesis of pulmonary lymphangioleiomyomatosis. Arch Pathol Lab Med. 2000;124(2):267-75.
15. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, et al. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature. 1994;370(6484):61-5, http://dx.doi.org/10.1038/370061a0.
16. Jackson C. Matrix metalloproteinases and angiogenesis. Curr Opin Nephrol Hypertens. 2002;11(3):295-9, http://dx.doi.org/10.1097/00041552-200205000-00005.
17. Odajima N, Betsuyaku T, Nasuhara Y, Inoue H, Seyama K, Nishimura M. Matrix metalloproteinases in blood from patients with LAM. Respir Med. 2009;103(1):124-9, http://dx.doi.org/10.1016/j.rmed.2008.07.017.
18. Zhe X, Yang Y, Jakkaraju S, Schuger L. Tissue inhibitor of metalloproteinase-3 downregulation in lymphangioleiomyomatosis: potential consequence of abnormal serum response factor expression. Am J Respir Cell Mol Biol. 2003;28(4):504-11, http://dx.doi.org/10.1165/rcmb.2002-0124OC.
19. Fukuda Y, Basset F, Soler P, Ferrans VJ, Masugi Y, Crystal RG. Intraluminal fibrosis and elastic fiber degradation lead to lung remodeling in pulmonary Langerhans cell granulomatosis (histiocytosis X). Am J Pathol. 1990;137(2):415-24.
20. Bhargava P, Rushin JM, Rusnock EJ, Hefter LG, Franks TJ, Sabnis SG, et al. Pulmonary light chain deposition disease: report of five cases and review of the literature. Am J Surg Pathol. 2007;31(2):267-76.
21. Khoo SK, Giraud S, Kahnoski K, Chen J, Motorna O, Nickolov R, et al. Clinical and genetic studies of Birt-Hogg-Dube syndrome. J Med Genet. 2002;39(12):906-12, http://dx.doi.org/10.1136/jmg.39.12.906.
22. Maffe A, Toschi B, Circo G, Giachino D, Giglio S, Rizzo A, et al. Constitutional FLCN mutations in patients with suspected Birt-Hogg-Dube syndrome ascertained for non-cutaneous manifestations. Clin Genet. 2011;79(4):345-54, http://dx.doi.org/10.1111/j.1399-0004.2010. 01480.x.
23. Butnor KJ, Guinee DG, Jr. Pleuropulmonary pathology of Birt-Hogg-Dube syndrome. Am J Surg Pathol. 2006;30(3):395-9.